CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

RXRXRECURSION PHARMACEUTICALS, INC.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $4.13 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$2.21B
RECENT INSIDER TRADES
  • 2026-10-07 · HERSHBERG ROBERT (Director) · SELL
  • 2026-10-07 · Borgeson Blake (Director) · SELL
  • 2026-10-07 · HERSHBERG ROBERT (Director) · OTHER
  • 2026-10-02 · Dar Zavain (Director) · OTHER
  • 2026-10-02 · Li Dean Y (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders370
Shares held441,743,093
Value$1.72B
Percent of shares outstanding82.52%
As of quarter end2026-06-30
RECENT NEWS
  • Recursion Pharmaceuticals director Blake Borgeson sells $242,000 in stock
  • Director Hershberg sells $125k in Recursion Pharmaceuticals stock
  • AbCellera and Recursion Pharmaceuticals: two AI-drug stocks, two different stories
  • Recursion Pharmaceuticals presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
RECURSION PHARMACEUTICALS, INC. (RXRX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit